|
1
|
Bellissimo F, Pinzone MR, Cacopardo B and
Nunnari G: Diagnostic and therapeutic management of hepatocellular
carcinoma. World J Gastroenterol. 21:12003–12021. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu CY, Chen KF and Chen PJ: Treatment of
liver cancer. Cold Spring Harb Perspect Med. 5:a0215352015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang J, Zhu S, Lin G, Song C and He Z:
Vitamin D enhances omega-3 polyunsaturated fatty acids-induced
apoptosis in breast cancer cells. Cell Biol Int. 41:890–897. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dormoy V, Beraud C, Lindner V, Coquard C,
Barthelmebs M, Brasse D, Jacqmin D, Lang H and Massfelder T:
Vitamin D3 triggers antitumor activity through targeting hedgehog
signaling in human renal cell carcinoma. Carcinogenesis.
33:2084–2093. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pan L, Matloob AF, Du J, Pan H, Dong Z,
Zhao J, Feng Y, Zhong Y, Huang B and Lu J: Vitamin D stimulates
apoptosis in gastric cancer cells in synergy with trichostatin
A/sodium butyrate-induced and 5-aza-2′-deoxycytidine-induced PTEN
upregulation. FEBS J. 277:989–999. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y, Chen C, Pan W, Gao M, He W, Mao R,
Lin T and Huang J: Comparative efficacy of vitamin D status in
reducing the risk of bladder cancer: A systematic review and
network meta-analysis. Nutrition. 32:515–523. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Louka ML, Fawzy AM, Naiem AM, Elseknedy
MF, Abdelhalim AE and Abdelghany MA: Vitamin D and K signaling
pathways in hepatocellular carcinoma. Gene. 629:108–116. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Caputo A, Pourgholami MH, Akhter J and
Morris DL: 1,25-Dihydroxyvitamin D(3) induced cell cycle arrest in
the human primary liver cancer cell line HepG2. Hepatol Res.
26:34–39. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iseki K, Tatsuta M, Uehara H, Iishi H,
Yano H, Sakai N and Ishiguro S: Inhibition of angiogenesis as a
mechanism for inhibition by 1alpha-hydroxyvitamin D3 and
1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by
azoxymethane in Wistar rats. Int J Cancer. 81:730–733. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Guo Q, Zhang Z, Bai N, Liu Z,
Xiong M, Wei Y, Xiang R and Tan X: VDR status arbitrates the
prometastatic effects of tumor-associated macrophages. Mol Cancer
Res. 12:1181–1191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeljic K, Supic G and Magic Z: New
insights into vitamin D anticancer properties: Focus on miRNA
modulation. Mol Genet Genomics. 292:511–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng Y and Croce CM: The role of MicroRNAs
in human cancer. Signal Transduct Target Ther. 1:150042016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ying J, Yu X, Ma C, Zhang Y and Dong J:
MicroRNA-363-3p is downregulated in hepatocellular carcinoma and
inhibits tumorigenesis by directly targeting specificity protein 1.
Mol Med Rep. 16:1603–1611. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dou C, Liu Z, Xu M, Jia Y, Wang Y, Li Q,
Yang W, Zheng X, Tu K and Liu Q: miR-187-3p inhibits the metastasis
and epithelial-mesenchymal transition of hepatocellular carcinoma
by targeting S100A4. Cancer Lett. 381:380–390. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li D, Liu X, Lin L, Hou J, Li N, Wang C,
Wang P, Zhang Q, Zhang P, Zhou W, et al: MicroRNA-99a inhibits
hepatocellular carcinoma growth and correlates with prognosis of
patients with hepatocellular carcinoma. J Biol Chem.
286:36677–36685. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue F, Yin J, Xu L and Wang B:
MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by
downregulating GATA6. Exp Ther Med. 13:2667–2674. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bandyopadhyay S, Mitra R, Maulik U and
Zhang MQ: Development of the human cancer MicroRNA network.
Silence. 1:62010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Long J, Jiang C, Liu B, Fang S and Kuang
M: MicroRNA-15a-5p suppresses cancer proliferation and division in
human hepatocellular carcinoma by targeting BDNF. Tumour Biol.
37:5821–5828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu B, Sun T, Wu G, Shang-Guan H, Jiang
ZJ, Zhang JR and Zheng YF: MiR-15a suppresses hepatocarcinoma cell
migration and invasion by directly targeting cMyb. Am J Transl Res.
9:520–532. 2017.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Feng Z, Peng C, Li D, Zhang D, Li X, Cui
F, Chen Y and He Q: E2F3 promotes cancer growth and is
overexpressed through copy number variation in human melanoma. Onco
Targets Ther. 11:5303–5313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun FB, Lin Y, Li SJ, Gao J, Han B and
Zhang CS: MiR-210 knockdown promotes the development of pancreatic
cancer via upregulating E2F3 expression. Eur Rev Med Pharmacol Sci.
22:8640–8648. 2018.PubMed/NCBI
|
|
23
|
Jeon SM and Shin EA: Exploring Vitamin D
metabolism and function in cancer. Exp Mol Med. 50:202018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ting HJ, Messing J, Yasmin-Karim S and Lee
YF: Identification of microRNA-98 as a therapeutic target
inhibiting prostate cancer growth and a biomarker induced by
Vitamin D. J Biol Chem. 288:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kasiappan R, Shen Z, Tse AK, Jinwal U,
Tang J, Lungchukiet P, Sun Y, Kruk P, Nicosia SV, Zhang X and Bai
W: 1,25-Dihydroxyvitamin D3 suppresses telomerase expression and
human cancer growth through MicroRNA-498. J Biol Chem.
287:41297–41309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang ZM, Wan XH, Sang GY, Zhao JD, Zhu QY
and Wang DM: miR-15a-5p suppresses endometrial cancer cell growth
via Wnt/β-catenin signaling pathway by inhibiting WNT3A. Eur Rev
Med Pharmacol Sci. 21:4810–4818. 2017.PubMed/NCBI
|
|
27
|
Kontos CK, Tsiakanikas P, Avgeris M,
Papadopoulos IN and Scorilas A: miR-15a-5p, A novel prognostic
biomarker, predicting recurrent colorectal adenocarcinoma. Mol
Diagn Ther. 21:453–464. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. Plos Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhan L, Zhang Y, Wang W, Song E, Fan Y and
Wei B: E2F1: A promising regulator in ovarian carcinoma. Tumour
Biol. 37:2823–2831. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gong W, Li J, Wang Y, Meng J and Zheng G:
miR-221 promotes lens epithelial cells apoptosis through
interacting with SIRT1 and E2F3. Chem Biol Interact. 306:39–46.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhong Q, Huang J, Wei J and Wu R: Circular
RNA CDR1as sponges miR-7-5p to enhance E2F3 stability and promote
the growth of nasopharyngeal carcinoma. Cancer Cell Int.
19:2522019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang H, Zheng W, Shuai X, Chang RM, Yu L,
Fang F and Yang LY: MicroRNA-424 inhibits Akt3/E2F3 axis and tumor
growth in hepatocellular carcinoma. Oncotarget. 6:27736–27750.
2015.PubMed/NCBI
|
|
33
|
Feber A, Clark J, Goodwin G, Dodson AR,
Smith PH, Fletcher A, Edwards S, Flohr P, Falconer A, Roe T, et al:
Amplification and overexpression of E2F3 in human bladder cancer.
Oncogene. 23:1627–1630. 2003. View Article : Google Scholar
|
|
34
|
Zeng X, Yin F, Liu X, Xu J, Xu Y, Huang J,
Nan Y and Qiu X: Upregulation of E2F transcription factor 3 is
associated with poor prognosis in hepatocellular carcinoma. Oncol
Rep. 31:1139–1146. 2014. View Article : Google Scholar : PubMed/NCBI
|
